Marco Cerrano
Impact in
- Hematology top 5%
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
- Chronic Myeloid Leukemia Treatments
- Genetics top 10%
- Myeloproliferative Neoplasms: Diagnosis and Treatment
Papers in
- Hematology 28
- Acute Myeloid Leukemia Research 17
- Chronic Myeloid Leukemia Treatments 13
- Hematopoietic Stem Cell Transplantation 6
- Genetics 17
- Chronic Lymphocytic Leukemia Research 9
- Myeloproliferative Neoplasms: Diagnosis and Treatment 8
- Co-authors
- Raphaël Itzykson (7 shared papers)Luisa Giaccone (13 shared papers)Benedetto Bruno (13 shared papers)Lionel Adès (7 shared papers)Marie Sébert (4 shared papers)Hervé Dombret (4 shared papers)Emmanuel Raffoux (4 shared papers)Nicolas Boissel (4 shared papers)
- Journals
- Blood (7 papers)Cancers (6 papers)Annals of Hematology (3 papers)Frontiers in Immunology (2 papers)Haematologica (2 papers)
- Partner nations
- ItalyFranceUnited States
In The Last Decade
Marco Cerrano
41 papers receiving 492 citations
Peers
Comparison fields: 5 of 43
- Hematology 281
- Genetics 119
- Oncology 127
- Internal Medicine 13
- Immunology 54
Countries citing papers authored by Marco Cerrano
This map shows the geographic impact of Marco Cerrano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marco Cerrano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marco Cerrano more than expected).
Fields of papers citing papers by Marco Cerrano
This network shows the impact of papers produced by Marco Cerrano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marco Cerrano. The network helps show where Marco Cerrano may publish in the future.
Co-authors
The 25 scholars most cited alongside Marco Cerrano, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 45 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 128 | |
| 2 | 2020 | 50 | |
| 3 | 2019 | 33 | |
| 4 | 2022 | 30 | |
| 5 | 2018 | 22 | |
| 6 | 2020 | 20 | |
| 7 | 2023 | 20 | |
| 8 | 2020 | 18 | |
| 9 | 2020 | 16 | |
| 10 | 2021 | 15 | |
| 11 | 2020 | 15 | |
| 12 | 2021 | 12 | |
| 13 | 2024 | 9 | |
| 14 | 2023 | 9 | |
| 15 | 2023 | 8 | |
| 16 | 2023 | 8 | |
| 17 | 2019 | 8 | |
| 18 | 2023 | 7 | |
| 19 | 2023 | 7 | |
| 20 | 2023 | 7 |
About Marco Cerrano
Marco Cerrano is a scholar working on Hematology, Genetics, Molecular Biology, Public Health, Environmental and Occupational Health and Oncology, having authored 45 papers that have together received 498 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (17 papers), Chronic Myeloid Leukemia Treatments (13 papers), Acute Lymphoblastic Leukemia research (9 papers), Chronic Lymphocytic Leukemia Research (9 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (8 papers), Hematopoietic Stem Cell Transplantation (6 papers), CAR-T cell therapy research (4 papers) and Protein Degradation and Inhibitors (3 papers). The work is most often cited by research in Hematology (281 citations), Genetics (119 citations), Oncology (127 citations), Internal Medicine (13 citations) and Immunology (54 citations). Marco Cerrano has collaborated with scholars based in Italy, France and United States. Frequent co-authors include Raphaël Itzykson, Luisa Giaccone, Benedetto Bruno, Lionel Adès, Marie Sébert, Hervé Dombret, Emmanuel Raffoux, Nicolas Boissel, Stefano D’Ardìa and Gérard Socié. Their work appears in journals such as Blood, Cancers, Annals of Hematology, Frontiers in Immunology and Haematologica.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.